A citation-based method for searching scientific literature

Juan Joseph Young, Tim Silber, Davide Bruno, Isaac Robert Galatzer-Levy, Nunzio Pomara, Charles Raymond Marmar. Front Psychiatry 2016
Times Cited: 30







List of co-cited articles
139 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Antidepressant effects of ketamine in depressed patients.
R M Berman, A Cappiello, A Anand, D A Oren, G R Heninger, D S Charney, J H Krystal. Biol Psychiatry 2000
6

Initial reliability and validity of a new retrospective measure of child abuse and neglect.
D P Bernstein, L Fink, L Handelsman, J Foote, M Lovejoy, K Wenzel, E Sapareto, J Ruggiero. Am J Psychiatry 1994
6

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.
Rita Haapakoski, Julia Mathieu, Klaus P Ebmeier, Harri Alenius, Mika Kivimäki. Brain Behav Immun 2015
409
6

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
779
6




Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.
Annamaria Cattaneo, Massimo Gennarelli, Rudolf Uher, Gerome Breen, Anne Farmer, Katherine J Aitchison, Ian W Craig, Christoph Anacker, Patricia A Zunsztain, Peter McGuffin,[...]. Neuropsychopharmacology 2013
241
6

An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
Rudolf Uher, Katherine E Tansey, Tracy Dew, Wolfgang Maier, Ole Mors, Joanna Hauser, Mojca Zvezdana Dernovsek, Neven Henigsberg, Daniel Souery, Anne Farmer,[...]. Am J Psychiatry 2014
183
6


The macrophage theory of depression.
R S Smith. Med Hypotheses 1991
512
6

Research domain criteria (RDoC): toward a new classification framework for research on mental disorders.
Thomas Insel, Bruce Cuthbert, Marjorie Garvey, Robert Heinssen, Daniel S Pine, Kevin Quinn, Charles Sanislow, Philip Wang. Am J Psychiatry 2010
6

Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features.
Dalibor Karlović, Alessandro Serretti, Nada Vrkić, Marko Martinac, Darko Marčinko. Psychiatry Res 2012
92
6

A review of the relationship between proinflammatory cytokines and major depressive disorder.
Juan Joseph Young, Davide Bruno, Nunzio Pomara. J Affect Disord 2014
191
6


Cytokine production and treatment response in major depressive disorder.
S Lanquillon, J C Krieg, U Bening-Abu-Shach, H Vedder. Neuropsychopharmacology 2000
436
6

Meta-review of depressive subtyping models.
Baumeister Harald, Parker Gordon. J Affect Disord 2012
150
6

Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression.
F Lamers, N Vogelzangs, K R Merikangas, P de Jonge, A T F Beekman, B W J H Penninx. Mol Psychiatry 2013
361
6

CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.
Vyara Valkanova, Klaus P Ebmeier, Charlotte L Allan. J Affect Disord 2013
432
6

BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis.
Maryna Polyakova, Katharina Stuke, Katharina Schuemberg, Karsten Mueller, Peter Schoenknecht, Matthias L Schroeter. J Affect Disord 2015
215
6

Biomarkers predicting antidepressant treatment response: how can we advance the field?
Christiana Labermaier, Mercè Masana, Marianne B Müller. Dis Markers 2013
41
6

Depression: an inflammatory illness?
Rajeev Krishnadas, Jonathan Cavanagh. J Neurol Neurosurg Psychiatry 2012
205
6


State-dependent changes in hippocampal grey matter in depression.
D Arnone, S McKie, R Elliott, G Juhasz, E J Thomas, D Downey, S Williams, J F W Deakin, I M Anderson. Mol Psychiatry 2013
152
6

Imaging predictors of remission to anti-depressant medications in major depressive disorder.
Kee F Chi, Mayuresh Korgaonkar, Stuart M Grieve. J Affect Disord 2015
23
8

Epigenetics and depressive disorders: a review of current progress and future directions.
Vania Januar, Richard Saffery, Joanne Ryan. Int J Epidemiol 2015
46
6

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.
Sidney H Kennedy, Raymond W Lam, Roger S McIntyre, S Valérie Tourjman, Venkat Bhat, Pierre Blier, Mehrul Hasnain, Fabrice Jollant, Anthony J Levitt, Glenda M MacQueen,[...]. Can J Psychiatry 2016
310
6

Brain Structural Effects of Antidepressant Treatment in Major Depression.
Nicola Dusi, Stefano Barlati, Antonio Vita, Paolo Brambilla. Curr Neuropharmacol 2015
42
6


Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
6


Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.
Ronald S Duman, George K Aghajanian, Gerard Sanacora, John H Krystal. Nat Med 2016
508
6

Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis.
Annamaria Cattaneo, Flavia Macchi, Giona Plazzotta, Begni Veronica, Luisella Bocchio-Chiavetto, Marco Andrea Riva, Carmine Maria Pariante. Front Cell Neurosci 2015
67
6

Circulating microRNAs as biomarkers for depression: Many candidates, few finalists.
Heidi Yuan, David Mischoulon, Maurizio Fava, Michael W Otto. J Affect Disord 2018
33
6



CSF miR-16 expression and its association with miR-16 and serotonin transporter in the raphe of a rat model of depression.
Qiong-Yan Shao, Fei You, Yong-Hua Zhang, Lin-Lin Hu, Wen-Juan Liu, Yi Liu, Jing Li, Sheng-Dong Wang, Ming-Fen Song. J Affect Disord 2018
10
20

White matter disturbances in major depressive disorder: a coordinated analysis across 20 international cohorts in the ENIGMA MDD working group.
Laura S van Velzen, Sinead Kelly, Dmitry Isaev, Andre Aleman, Lyubomir I Aftanas, Jochen Bauer, Bernhard T Baune, Ivan V Brak, Angela Carballedo, Colm G Connolly,[...]. Mol Psychiatry 2020
38
6

Targeting the Microbiota-Gut-Brain Axis: Prebiotics Have Anxiolytic and Antidepressant-like Effects and Reverse the Impact of Chronic Stress in Mice.
Aurelijus Burokas, Silvia Arboleya, Rachel D Moloney, Veronica L Peterson, Kiera Murphy, Gerard Clarke, Catherine Stanton, Timothy G Dinan, John F Cryan. Biol Psychiatry 2017
280
6

Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects.
Brian A Hoshaw, Jessica E Malberg, Irwin Lucki. Brain Res 2005
228
3

Approval of novel biomarkers: FDA's perspective and major requests.
Uwe Scherf, Robert Becker, Maria Chan, Sally Hojvat. Scand J Clin Lab Invest Suppl 2010
7
14

Pharmacogenomics of suicidal events.
David Brent, Nadine Melhem, Gustavo Turecki. Pharmacogenomics 2010
24
4

Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization.
Joshua Greene, Mounira Banasr, Boyoung Lee, Jennifer Warner-Schmidt, Ronald S Duman. Neuropsychopharmacology 2009
102
3


A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013.
David A Mrazek, John C Hornberger, C Anthony Altar, Irina Degtiar. Psychiatr Serv 2014
222
3

A comparison of antidepressant use in Nova Scotia, Canada and Australia.
Alesha J Smith, Ingrid Sketris, Charmaine Cooke, David Gardner, Steve Kisely, Susan E Tett. Pharmacoepidemiol Drug Saf 2008
19
5

The current and future state of companion diagnostics.
Amit Agarwal, Dan Ressler, Glenn Snyder. Pharmgenomics Pers Med 2015
40
3

Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes.
C A Altar, J M Carhart, J D Allen, D K Hall-Flavin, B M Dechairo, J G Winner. Pharmacogenomics J 2015
59
3

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
Theo Vos, Abraham D Flaxman, Mohsen Naghavi, Rafael Lozano, Catherine Michaud, Majid Ezzati, Kenji Shibuya, Joshua A Salomon, Safa Abdalla, Victor Aboyans,[...]. Lancet 2012
3

The Patient Health Questionnaire-2: validity of a two-item depression screener.
Kurt Kroenke, Robert L Spitzer, Janet B W Williams. Med Care 2003
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.